# GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

> **NCT00293462** · PHASE3 · COMPLETED · sponsor: **Marilyn Dodd** · enrollment: 91 (actual)

## Conditions studied

- Head and Neck Cancer
- Mucositis Oral
- Radiation Toxicity
- Tongue Cancer

## Interventions

- **BIOLOGICAL:** sargramostim
- **OTHER:** oral salt and soda mouthwash

## Key facts

- **NCT ID:** NCT00293462
- **Lead sponsor:** Marilyn Dodd
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06-07
- **Primary completion:** 2009-12-31
- **Final completion:** 2009-12-31
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2021-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293462, "GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00293462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*